Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentric Trial

NCT00914095 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT00914095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00914095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentric Trial
Lead sponsor
University Hospital, Lille
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2011
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, gait disorders, neurologic, parkinson's disease